The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies

SIMPLE SUMMARY: Monitoring the response to treatment in hematologic malignancies is essential in defining the best way to optimize patient management. In general, achieving a deeper response has been shown to lead to a better prognosis, and the techniques used to study the minimal residual disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Colmenares, Rafael, Álvarez, Noemí, Barrio, Santiago, Martínez-López, Joaquín, Ayala, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909350/
https://www.ncbi.nlm.nih.gov/pubmed/35267616
http://dx.doi.org/10.3390/cancers14051310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909350/
https://www.ncbi.nlm.nih.gov/pubmed/35267616
http://dx.doi.org/10.3390/cancers14051310

Ejemplares similares